These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 11161856

  • 1. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.
    Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA.
    Gynecol Oncol; 2001 Feb; 80(2):176-80. PubMed ID: 11161856
    [Abstract] [Full Text] [Related]

  • 2. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.
    Zweemer RP, van Diest PJ, Verheijen RH, Ryan A, Gille JJ, Sijmons RH, Jacobs IJ, Menko FH, Kenemans P.
    Gynecol Oncol; 2000 Jan; 76(1):45-50. PubMed ID: 10620440
    [Abstract] [Full Text] [Related]

  • 3. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [Abstract] [Full Text] [Related]

  • 4. A genetic epidemiological study of carcinoma of the fallopian tube.
    Aziz S, Kuperstein G, Rosen B, Cole D, Nedelcu R, McLaughlin J, Narod SA.
    Gynecol Oncol; 2001 Mar; 80(3):341-5. PubMed ID: 11263928
    [Abstract] [Full Text] [Related]

  • 5. Preventive gynecologic surgery for BRCA1/2 carriers--information for decision-making.
    Quillin JM, Boardman CH, Bodurtha J, Smith T.
    Gynecol Oncol; 2001 Oct; 83(1):168-70. PubMed ID: 11585435
    [No Abstract] [Full Text] [Related]

  • 6. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
    Vicus D, Finch A, Rosen B, Fan I, Bradley L, Cass I, Sun P, Karlan B, McLaughlin J, Narod SA, Hereditary Ovarian Cancer Clinical Study Group.
    Gynecol Oncol; 2010 Aug 01; 118(2):155-9. PubMed ID: 20452659
    [Abstract] [Full Text] [Related]

  • 7. BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?
    Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY.
    Obstet Gynecol; 2005 Dec 01; 106(6):1327-34. PubMed ID: 16319259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Carcinoma of the fallopian tube after prophylactic laparoscopic ovariectomy in a patient with a BRCAI mutation].
    Dijkhuizen FP, Huisman A, Boonstra H, Aalders AL.
    Ned Tijdschr Geneeskd; 2003 May 03; 147(18):877-9. PubMed ID: 12756880
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report.
    Rose PG, Shrigley R, Wiesner GL.
    Gynecol Oncol; 2000 May 03; 77(2):319-20. PubMed ID: 10785486
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
    Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH.
    Obstet Gynecol; 2006 Sep 03; 108(3 Pt 1):515-20. PubMed ID: 16946209
    [Abstract] [Full Text] [Related]

  • 14. BRCA2 germline mutations in primary cancer of the fallopian tube.
    Casarsa S, Puglisi F, Baudi F, De Paola L, Venuta S, Piga A, Di Loreto C, Marchesoni D, D'Elia AV, Damante G.
    Oncol Rep; 2004 Aug 03; 12(2):313-6. PubMed ID: 15254695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
    Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J.
    J Clin Oncol; 2005 Jan 01; 23(1):127-32. PubMed ID: 15625367
    [Abstract] [Full Text] [Related]

  • 19. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
    Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ.
    Gynecol Oncol; 2006 Jan 01; 100(1):58-64. PubMed ID: 16137750
    [Abstract] [Full Text] [Related]

  • 20. Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers.
    Carcangiu ML, Radice P, Manoukian S, Spatti G, Gobbo M, Pensotti V, Crucianelli R, Pasini B.
    Int J Gynecol Pathol; 2004 Jan 01; 23(1):35-40. PubMed ID: 14668548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.